The trial will include patients with locally advanced or metastatic HER2-positive, PD-L1-positive gastric or gastroesophageal junction cancer.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

Medscape Gastroenterology, March 11, 2024 Trastuzumab Deruxtecan: Effects in Multiple Cancer Types Dr Maurie Markman discusses the concept of focusing on a particular molecular target and then ...

Game 2 of the finals series will also be played at the MOA Arena on Sunday, March 16. The Tropang Giga and the Gin Kings will have one week before they fight for the championship after wrapping up ...